Global Skin Grafts Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• November 2022, AVITA Medical, Inc., a regenerative medicine company that develops and commercializes first-in-class equipment and autologous cellular treatments for skin restoration, announced today that the FDA had designated the RECELL System as a Breakthrough Device for both its pitched soft tissue repair indication and its vitiligo indication.

• July 2020, Lancer Skincare has announced the release of its first skincare exfoliation equipment, the Pro Polish Microdermabrasion equipment, which is presently available exclusively on QVC. The launch of the Pro Polish Microdermabrasion Device draws on Dr. Harold Lancer's 30 years of dermatology invention, research and practice and marks Lancer Skincare's entry into a new cosmetic market.

The Global Skin Grafts Market is segmented by type into autologous, isogenic, allogenic, xenogenic, and prosthetic grafts. Autologous skin grafts, derived from the patient's own body, are the most commonly used due to their lower risk of rejection and better healing outcomes. Isogenic grafts, taken from genetically identical individuals, and allogenic grafts, obtained from donors, are also used in cases where autologous grafting is not possible. Xenogenic grafts, harvested from animals, are less commonly used but can be an alternative in specific scenarios. Lastly, prosthetic grafts are synthetic materials used for wound closure in cases where biological grafts are unsuitable. The demand for these different types of skin grafts is driven by the nature of the wound, the availability of donor skin, and the specific needs of the patient.

The market is also segmented by graft thickness, which includes split-thickness, full-thickness, and composite grafts. Split-thickness grafts involve the removal of the epidermis and a portion of the dermis, commonly used for burn treatment and larger wound areas. Full-thickness grafts, which include both the epidermis and dermis, are used for areas requiring more durability and cosmetic outcomes, such as reconstructive surgery. Composite grafts combine both skin and underlying tissue to offer greater functionality and aesthetic results, especially in complex surgeries. The choice of graft thickness is determined by the severity of the wound, desired cosmetic outcome, and the patient’s overall health.

By application, the Global Skin Grafts Market is segmented into surgical wounds, burns, diabetic ulcers, reconstructive surgery, and others. Burns and surgical wounds are the most common applications, as skin grafting is often required to close large wounds or replace lost skin. Diabetic ulcers, particularly in the elderly population, are a growing concern due to the increasing prevalence of diabetes and its complications, driving the demand for skin grafts. Reconstructive surgery also represents a significant application, as skin grafts are used to restore appearance and functionality after trauma or surgical removal of skin. The demand across these applications is rising with the growing incidence of chronic diseases, traumatic injuries, and advances in surgical techniques. The end-user segmentation includes hospitals, specialty clinics, and others. Hospitals dominate the market, given their comprehensive infrastructure for handling complex skin graft surgeries. Specialty clinics, particularly those focused on plastic surgery and wound care, are increasingly involved in skin graft procedures, providing personalized treatment. Lastly, the others category includes outpatient centers and rehabilitation facilities, contributing to the market through less invasive skin graft applications for smaller wounds.

Global Skin Grafts Segment Analysis

In this report, the Global Skin Grafts Market has been segmented by Type, Graft Thickness, Application, End-Use and Geography.

Global Skin Grafts Market, By Application

The Global Skin Grafts Market has been segmented by Application into Surgical Wounds, Burns, Diabetic Ulcers, Reconstructive Surgery, and Others.

The Global Skin Grafts Market is segmented by application, with key areas including surgical wounds, burns, diabetic ulcers, reconstructive surgery, and others. Surgical wounds remain one of the largest applications for skin grafts, driven by the increasing number of surgeries, such as those related to trauma, orthopedic conditions, and cancer treatments. Skin grafts are used to promote faster healing and minimize scarring in surgical wounds, enhancing patient recovery. This segment is expanding with advancements in surgical techniques and increased awareness of the benefits of skin grafting in improving post-operative outcomes.

The burns segment also plays a significant role in the growth of the skin grafts market. Burns, particularly those involving large surface areas or deep tissue damage, require skin grafts for effective healing and to prevent infection. With the rising incidence of burn injuries globally and improvements in burn treatment protocols, the demand for skin grafts, especially those made from autologous (patient's own) and allogeneic (donor-based) skin, is expected to grow. Skin grafts help regenerate healthy skin, reduce scarring, and restore functional and aesthetic outcomes, which are essential in burn recovery.

Diabetic ulcers and reconstructive surgery are also growing applications for skin grafts. Diabetic ulcers, which are common in diabetic patients due to poor circulation and prolonged wound healing, often require grafting to prevent complications like infection and amputations. Skin grafts are particularly effective in diabetic wound healing as they provide a protective barrier and promote tissue regeneration. Similarly, in reconstructive surgery, skin grafts are used to repair or replace damaged or missing skin following accidents, congenital deformities, or surgeries, including breast reconstruction after mastectomy. As reconstructive surgery techniques advance and the global incidence of conditions like diabetes and trauma increases, the demand for skin grafts is anticipated to continue growing.

Global Skin Grafts Market, By End User

The Global Skin Grafts Market has been segmented by End User into Hospitals, Specialty Clinics, and Others.

The Global Skin Grafts Market is segmented by end user into hospitals, specialty clinics, and others, each playing a vital role in the application and demand for skin grafts. Hospitals represent the largest end-user segment, as they handle a significant number of cases involving burns, surgical wounds, diabetic ulcers, and reconstructive surgery. Hospitals provide comprehensive treatment options, including skin grafting procedures, which require specialized equipment, skilled healthcare professionals, and infrastructure to manage complex wound healing cases. The demand for skin grafts in hospitals is fueled by the rising number of surgical interventions and traumatic injuries, along with an aging population requiring more advanced care.

Specialty clinics form a growing segment in the skin grafts market. These clinics typically focus on specific areas of care, such as dermatology, wound care, or plastic surgery, where skin grafts are frequently used for treating conditions like chronic wounds, burns, and post-surgical recovery. Patients often seek specialized treatment in these clinics for their expertise in managing skin grafting procedures and ensuring optimal healing. As medical technologies improve and more patients seek personalized treatments, specialty clinics have become key providers of skin graft services, contributing to the market's growth.

The others category includes a diverse range of healthcare settings that also utilize skin grafts, such as ambulatory surgical centers, rehabilitation centers, and home care settings where patients may receive post-operative care. These facilities support less complex or outpatient procedures and play a role in skin graft procedures for minor burn cases or smaller wound healing. As these settings grow in number and capability, the demand for skin grafts continues to expand across various types of care facilities, promoting access to specialized skin care services in diverse environments.

Global Skin Grafts Market, By Geography

In this report, the Global Skin Grafts Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Skin Grafts Market Share (%), by Geographical Region, 2024

North America, as one of the leading segments, exhibits a robust market owing to advanced healthcare infrastructure, rising prevalence of chronic wounds, and a growing elderly population. The region's technological advancements in skin grafting techniques and a strong presence of key market players further bolster market growth. Europe stands as another prominent market segment, characterized by increasing incidences of burns, trauma cases, and a rising focus on cosmetic surgeries. The region's well-established healthcare systems, favorable reimbursement policies, and growing adoption of innovative skin grafting products contribute to its substantial market share.

Asia Pacific emerges as a burgeoning market segment driven by rapid urbanization, improving healthcare facilities, and a rising awareness regarding reconstructive surgeries. The region's large patient pool, particularly in countries like China and India, presents immense growth opportunities for market players. The Middle East and Africa, along with Latin America, exhibit steady growth trajectories, propelled by improving healthcare infrastructure, rising disposable incomes, and increasing investments in healthcare. Challenges such as limited access to advanced healthcare facilities and high treatment costs hinder market growth in these regions, necessitating strategic initiatives to tap into their latent potential.

This report provides an in depth analysis of various factors that impact the dynamics of Global Skin Grafts Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Skin Grafts Market include;

• Avita Medical
• B. Braun Melsungen AG
• De Soutter Medical Limited
• Integra Lifesciences Corporation
• MiMedx
• Nouvag AG
• Organogenesis, Inc.
• Surtex Instruments Limited
• Tissue Regenix
• Zimmer Biomet

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis